Compounds > 1,4-bis(2-(3,5-dichloropyridyloxy))benzene
Page last updated: 2024-11-04

1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Carcinoma, Non-Small Cell Lung

1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukumasu, H1
Rochetti, AL1
Pires, PR1
Silva, ER1
Mesquita, LG1
Strefezzi, RF1
De Carvalho, DD1
Dagli, ML1

Other Studies

1 other study available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Carcinoma, Non-Small Cell Lung

ArticleYear
Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Androstenols; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cons

2014